Airway Colonization in Children with Medical Complexity: Challenges and Management Strategies

TL;DR

This paper reviews the challenges of managing airway infections in children with complex medical needs and highlights the importance of personalized treatment strategies.

Contribution

The paper provides a comprehensive review of management strategies for airway colonization in children with medical complexity.

Findings

Airway colonization by pathogens like Pseudomonas aeruginosa and MRSA is common in children with medical complexity.

Management often involves airway clearance techniques and tailored antibiotic therapies.

Personalized therapeutic approaches are needed to reduce respiratory complications and improve outcomes.

Abstract

Over recent years, advances in medical care have significantly improved the survival of children with severe chronic conditions. These children, referred to as children with medical complexity (CMC), present unique and demanding healthcare challenges. Although definitions of CMC remain inconsistent, these patients are typically characterized by chronic, often severe conditions requiring daily specialized treatments and the use of various medical devices. CMC represent a substantial burden for healthcare systems due to their high medical costs, and place considerable strain on caregivers, who must provide continuous assistance. Airway colonization by pathogens such as Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus (MRSA), and Haemophilus influenzae is common in CMC and contributes to recurrent respiratory infections, increased hospitalizations, and progressive lung damage. The management of airway colonization in this population is a topic of ongoing debate, often involving a combination of airway clearance techniques (ACT) and antibiotic therapies. Antibiotics may be administered systemically, nebulized, or in combination, depending on the clinical context and severity of the condition. This review highlights the complexities of managing airway colonization in CMC, emphasizing the need for tailored therapeutic approaches to mitigate respiratory complications and improve outcomes.

Figures